Keck School of Medicine of USC to focus on Hispanic patients with NAFLD in multi-omics study

The Keck School of Medicine of USC has received funding from the National Institutes of Health as part of a five-year, $50.3 million “multi-omics” study of human health and disease involving six sites.

Praxis prices $150M public stock offering ahead of four topline neuro readouts in 2024

Boston-based Praxis Precision Medicines announced Thursday the pricing of a $150 million public stock offering, with an expected close date around Jan. 16. Praxis is

January 12, 2024

AI model predicts patient decline with near-perfect accuracy using facial expressions

Study develops a ConvLSTM model that accurately predicts patient deterioration based on facial expressions, achieving 99.89% accuracy, with potential to improve early detection in healthcare

August 14, 2024

Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A

Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of immunosuppressive therapy

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.